US8536167 — Methods for treating ophthalmic, otic, or nasal infections
Method of Use · Assigned to Alcon Research LLC · Expires 2031-08-08 · 5y remaining
What this patent protects
This patent protects methods for treating ophthalmic, otic, or nasal infections using a composition containing finafloxacin or a finafloxacin derivative.
USPTO Abstract
The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprising finafloxacin or a finafloxacin derivative. The compositions are suitable for the treatment of ophthalmic, otic, or nasal infections.
Drugs covered by this patent
- Xtoro (FINAFLOXACIN) · Fonseca Biosciences
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-1679 |
— | Xtoro |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.